Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational

A Prospective, Observational, Multicenter Study of Patients Following Initiation of a New Course of Treatment for Overactive Bladder (OAB)

ClinicalTrials.gov ID: NCT02386072

Public ClinicalTrials.gov record NCT02386072. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 8:47 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Non-interventional, Registry Study of Patients Initiating a Course of DrugTherapy for Overactive Bladder (OAB)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A study to identify factors that are associated with improved effectiveness in pharmacologic therapy of Overactive Bladder, from the patient perspective primarily measured by OAB-Q-SF (Overactive Bladder Questionnaire Short Form)

Study identification

NCT ID
NCT02386072
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Enrollment
1,524 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 5, 2015 (Actual)
Primary completion
Aug 4, 2017 (Actual)
Completion
Aug 4, 2017 (Actual)
Last update posted
Oct 16, 2024

2015 – 2017

United States locations

U.S. sites
75
U.S. states
33
U.S. cities
59
Facility City State ZIP Site status
Site US1051 Birmingham Alabama 35235 —
Site US1094 Birmingham Alabama 35242 —
Site US1010 Huntsville Alabama 35801 —
Site US1020 Mobile Alabama 36604 —
Site US1006 Goodyear Arizona 85395 —
Site US1036 Mesa Arizona 85206 —
Site US1028 Phoenix Arizona 85018 —
Site US1100 Tucson Arizona 85715 —
Site US1083 Tucson Arizona 85741 —
Site US1114 Little Rock Arkansas 72205 —
Site US1061 Little Rock Arkansas 72212 —
Site US1112 Garden Grove California 92844 —
Site US1104 Sacramento California 95817 —
Site US1013 Santa Ana California 92701 —
Site US1090 Northglenn Colorado 80234 —
Site US1050 Hialeah Florida 33012 —
Site US1068 Miami Florida 33015 —
Site US1079 Miami Florida 33144 —
Site US1031 Miami Florida 33155 —
Site US1032 Miami Florida 33155 —
Site US1044 Miami Florida 33155 —
Site US1018 Miami Florida 33173 —
Site US1098 Miami Florida 33175 —
Site US1075 Miami Florida 33185 —
Site US1048 North Miami Beach Florida 33162 —
Site US1093 Ocoee Florida 34761 —
Site US1055 Pompano Beach Florida 33060 —
Site US1042 Atlanta Georgia 30342 —
Site US1035 Columbus Georgia 31909 —
Site US1009 Marietta Georgia 30067 —
Site US1016 Idaho Falls Idaho 83404 —
Site US1046 Lake Barrington Illinois 60010 —
Site US1019 Evansville Indiana 47714 —
Site US1034 Evansville Indiana 47725 —
Site US1097 Muncie Indiana 47304 —
Site US1017 Council Bluffs Iowa 51503 —
Site US1064 Overland Park Kansas 66210 —
Site US1077 Lafayette Louisiana 70503 —
Site US1058 Annapolis Maryland 21401 —
Site US1088 Burlington Massachusetts 01805 —
Site US1059 Fall River Massachusetts 02720 —
Site US1076 Watertown Massachusetts 02472 —
Site US1089 Worcester Massachusetts 01605 —
Site US1062 Hamtramck Michigan 48212 —
Site US1047 Hazelwood Missouri 63042 —
Site US1082 St Louis Missouri 63128 —
Site US1105 St Louis Missouri 63141 —
Site US1102 Omaha Nebraska 68114 —
Site US1039 Omaha Nebraska 68124 —
Site US1043 Las Vegas Nevada 89128 —
Site US1052 Las Vegas Nevada 89146 —
Site US1085 New Brunswick New Jersey 08901 —
Site US1001 Sicklerville New Jersey 08081 —
Site US1008 Albuquerque New Mexico 87106 —
Site US1103 Buffalo New York 14203 —
Site US1096 Garden City New York 11530 —
Site US1106 New York New York 10003 —
Site US1111 New York New York 10065 —
Site US1040 Newburgh New York 12550 —
Site US1045 Poughkeepsie New York 12601 —
Site US1060 Raleigh North Carolina 27609 —
Site US1007 Hilliard Ohio 43026 —
Site US1021 Downingtown Pennsylvania 19335 —
Site US1070 Providence Rhode Island 02914 —
Site US1004 Myrtle Beach South Carolina 29588 —
Site US1084 Sioux Falls South Dakota 57104 —
Site US1015 Clarksville Tennessee 37040 —
Site US1037 Fort Worth Texas 76132 —
Site US1080 Houston Texas 77043 —
Site US1067 Houston Texas 77055 —
Site US1057 Katy Texas 77450 —
Site US1012 Plano Texas 75093 —
Site US1099 Virginia Beach Virginia 23462 —
Site US1086 Seattle Washington 98104 —
Site US1071 Monroe Wisconsin 53566 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 17 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02386072, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 16, 2024 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02386072 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →